News & StoriesCheck out our latest stories31/03/2025Press releaseOctapharma Announces Superior Haemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate over Frozen Plasma in Cardiac Surgical Bleeding06/03/2025Press releaseNHS patients receive medicines manufactured by Octapharma using UK-donated plasma for the first time in almost 30 years08/03/2023Corporate newsCelebrating International Women's Day03/03/2025Corporate newsSimplifying IgG therapy with flexIGShow more
31/03/2025Press releaseOctapharma Announces Superior Haemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate over Frozen Plasma in Cardiac Surgical Bleeding
06/03/2025Press releaseNHS patients receive medicines manufactured by Octapharma using UK-donated plasma for the first time in almost 30 years
Octapharma lectures27/04/2025SCA 2025Octapharma Symposium18/03/2025ISICEM 2025Octapharma Symposium05/02/2025EAHAD 2025Octapharma Symposium: Is it time for equity in the treatment of severe VWD and severe haemophilia A?Check all our events
05/02/2025EAHAD 2025Octapharma Symposium: Is it time for equity in the treatment of severe VWD and severe haemophilia A?
Patient EngagementOctapharma takes an active role in our communityWe sponsor and support organisations worldwide.Learn how we engage with patients
)